(RECS) Columbia Trust I - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US19761L7064

Large-Cap Stocks, Mid-Cap Stocks, Blend Equities

Description: RECS Columbia Trust I

The Columbia Research Enhanced Core ETF (RECS) is an exchange-traded fund that tracks a custom index comprised of a subset of companies within the Russell 1000 Index, aiming to represent the performance of U.S. large- and mid-cap growth and value companies. By employing a rules-based methodology, the index typically holds between 325 and 400 securities, although this number can vary as there are no constraints on the number of holdings.

The funds investment strategy involves allocating at least 80% of its assets to the securities included in the index, thereby providing broad exposure to the U.S. large- and mid-cap market segments. This approach allows investors to tap into the overall performance of these companies, capturing both growth and value aspects of the market.

Analyzing the funds recent performance and technical indicators, we observe that the last price is $35.80, indicating a positive trend as it is above the 20-day Simple Moving Average (SMA) of $35.13 and significantly above the 50-day SMA of $33.42. The Average True Range (ATR) stands at 0.41, or 1.16%, suggesting moderate daily price volatility. Given the current price is near the 52-week high of $36.12 and substantially above the 52-week low of $29.40, it indicates a strong upward trend.

Considering the Assets Under Management (AUM) of $2,788.73 million USD, the fund demonstrates a considerable scale, potentially offering liquidity and stability for investors. By combining the technical indicators with the fundamental data, a forecast can be made. The upward trend, supported by the funds price being above key SMAs and near its 52-week high, coupled with its substantial AUM, suggests a potential for continued growth. However, the proximity to the 52-week high may indicate a potential for consolidation or a slight pullback before further growth. Investors should monitor the SMA20 and SMA50 for signs of trend continuation or reversal.

Forecasting the next movement for RECS involves analyzing the interplay between its technical indicators and fundamental data. If the upward trend continues, with the price maintaining its position above the SMA20 and SMA50, we can expect the fund to potentially reach or surpass its 52-week high. Conversely, a drop below the SMA50 could signal a reversal, potentially leading to a retest of lower support levels. The ATR suggests that significant daily swings are possible, so investors should be prepared for volatility.

Additional Sources for RECS ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

RECS ETF Overview

Market Cap in USD 3,079m
Category Large Blend
TER 0.15%
IPO / Inception 2019-09-25

RECS ETF Ratings

Growth Rating 76.6
Fundamental -
Dividend Rating 39.1
Rel. Strength 0.62
Analysts -
Fair Price Momentum 36.82 USD
Fair Price DCF -

RECS Dividends

Dividend Yield 12m 1.06%
Yield on Cost 5y 2.24%
Annual Growth 5y 7.12%
Payout Consistency 69.6%
Payout Ratio %

RECS Growth Ratios

Growth Correlation 3m 97.4%
Growth Correlation 12m 46.3%
Growth Correlation 5y 87.5%
CAGR 5y 17.15%
CAGR/Max DD 5y 0.78
Sharpe Ratio 12m 1.22
Alpha 1.35
Beta 0.956
Volatility 10.29%
Current Volume 420.7k
Average Volume 20d 421.4k
Stop Loss 36.1 (-2.9%)
What is the price of RECS shares?
As of July 15, 2025, the stock is trading at USD 37.18 with a total of 420,723 shares traded.
Over the past week, the price has changed by +0.22%, over one month by +4.15%, over three months by +16.88% and over the past year by +13.35%.
Is Columbia Trust I a good stock to buy?
Yes. Based on ValueRay's Analyses, Columbia Trust I (NYSE ARCA:RECS) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 76.62 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RECS is around 36.82 USD . This means that RECS is currently overvalued and has a potential downside of -0.97%.
Is RECS a buy, sell or hold?
Columbia Trust I has no consensus analysts rating.
What are the forecasts for RECS share price target?
According to our own proprietary Forecast Model, RECS Columbia Trust I will be worth about 42.5 in July 2026. The stock is currently trading at 37.18. This means that the stock has a potential upside of +14.28%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 42.5 14.3%